TVRD Competitors & Alternatives
Compare Tvardi Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
TVRD
Main Stock$1.18
+2.16%
Tradestie Score
31
Market Cap
$354.65M
Analyst Upside
+715.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.24
+0.05%
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.36
-4.69%
|
$133.50M | - | 41 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.61
-0.19%
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$29.54
-3.53%
|
$110.20M | - | 35 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.11
-3.42%
|
$84.52M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.84
-2.85%
|
$67.94M | - | 48 | Compare |
|
XXII
22nd Century Group Inc.
|
$0.77
-40.76%
|
$6.50M | 0.0 | 31 | Compare |
|
DOGP
DOGP
|
- | - | - | - | Compare |
|
CANN
CANN
|
- | - | - | - | Compare |
|
AMMJ
AMMJ
|
- | - | - | - | Compare |
More TVRD Analysis
Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry